| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327450 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
This nationwide study comparing patients with early stage borderline and invasive epithelial tumors of the ovary confirms our previous pilot study that showed a lower incidence of BRCA mutations in patients with borderline tumors. Our results suggest that the genetic predisposition and the molecular mechanisms underlying tumor initiation differ between invasive and borderline tumors of the ovary.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Walter H. Gotlieb, Angela Chetrit, Joseph Menczer, Galit Hirsh-Yechezkel, Flora Lubin, Eitan Friedman, Baruch Modan, Gilad Ben-Baruch, for the National Israel Ovarian Cancer Study Group for the National Israel Ovarian Cancer Study Group,